drugset / Trial / NCT00347373

Effect of Conjugated Linoleic Acid Supplement on Body Composition

NCT00347373

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this clinical trial is to examine the effects of a low and high dose of conjugated linoleic acid supplement on body composition in obese humans. Individuals with a body mass index between 30 and 35kg/m2 are randomized to receive either placebo, 3.2gCLA, or 6.4g CLA daily for twelve weeks. Changes in body composition, weight, and clinical laboratory values are compared between the three groups.

Timeline

Start
2004-08
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Conjugated Linoleic Acid Unknown 3.2 g
Subject Conjugated Linoleic Acid Unknown 6.4 g

Indications